RISK OF MEMANTINE INITIATION WITH USE OF ANTIMUSCARINICS AND/OR CHOLINESTERASE INHIBITORS IN OLDER ADULTS WITH ALZHEIMER'S DISEASE

被引:0
|
作者
Chikermane, S. [1 ]
Sherer, J. T. [2 ]
Holmes, H. M. [3 ]
Aparasu, R. R. [2 ]
机构
[1] Univ Houston, Coll Pharm, Irvine, CA USA
[2] Univ Houston, Coll Pharm, Houston, TX 77030 USA
[3] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EPH163
引用
收藏
页码:S464 / S465
页数:2
相关论文
共 50 条
  • [1] ANTIPSYCHOTIC INITIATION AMONG OLDER ALZHEIMER'S DISEASE PATIENTS USING CHOLINESTERASE INHIBITORS AND/OR ANTIMUSCARINICS
    Chikermane, S.
    Holmes, H. M.
    Sherer, J. T.
    Aparasu, R. R.
    VALUE IN HEALTH, 2022, 25 (07) : S453 - S453
  • [2] Cholinesterase Inhibitors and Memantine in Adults with Alzheimer Disease
    Santaguida, P. Lina
    Shamliyan, Tatyana A.
    Goldmann, David R.
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (10): : 1044 - 1047
  • [3] THE IMPACT OF MEMANTINE AND CHOLINESTERASE INHIBITORS INITIATION FOR ALZHEIMER'S DISEASE ON THE USE OF ANTIPSYCHOTICS AGENTS: ANALYSIS USING THE RAMQ DATABASE
    Lachaine, J.
    Beauchemin, C.
    Crochard, A.
    Bineau, S.
    VALUE IN HEALTH, 2012, 15 (07) : A558 - A558
  • [4] Risk of antimuscarinic initiation with cholinesterase inhibitor use in Alzheimer's disease
    Chikermane, Soumya G.
    Li, Jieni
    Aparasu, Rajender R.
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2025, 128
  • [5] Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease
    Parsons, Chris G.
    Danysz, Wojciech
    Dekundy, Andrzej
    Pulte, Irena
    NEUROTOXICITY RESEARCH, 2013, 24 (03) : 358 - 369
  • [6] Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
    Chris G. Parsons
    Wojciech Danysz
    Andrzej Dekundy
    Irena Pulte
    Neurotoxicity Research, 2013, 24 : 358 - 369
  • [7] A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer's disease
    Ebrahem, Anees Shajhan
    Oremus, Mark
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (11) : 1245 - 1259
  • [8] Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease
    Rabins, Peter V.
    Lyketsos, Constantine G.
    NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (11): : 578 - 579
  • [9] Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease
    Peter V Rabins
    Constantine G Lyketsos
    Nature Clinical Practice Neurology, 2006, 2 : 578 - 579
  • [10] RISK OF ANTIMUSCARINIC INITIATION WITH CHOLINESTERASE INHIBITOR USE IN PATIENTS WITH ALZHEIMER'S DISEASE
    Chikermane, S.
    Holmes, H. M.
    Sherer, J. T.
    Aparasu, R. R.
    VALUE IN HEALTH, 2022, 25 (07) : S291 - S291